Quick View
| Metric | Current Period | Same Period of Previous Year | YoY |
|---|---|---|---|
| Revenue | ¥16861.9B | ¥14783.4B | +14.1% |
| Operating Income | - | - | - |
| Profit Before Tax | ¥4409.3B | ¥3306.4B | +33.4% |
| Net Income | ¥3297.8B | ¥2479.8B | +33.0% |
| ROE | 4.9% | 3.8% | - |
Executive Summary
The sharp expansion in investment gains and the improvement in underwriting profit at domestic non-life insurers made dual contributions, resulting in higher revenue and earnings. Revenue (insurance revenue) was ¥16,861.9B (+14.1% YoY), profit before tax was ¥4,409.3B (+33.4%), and net income attributable to owners of the parent was ¥3,286.2B (+33.4%). Other investment gains surged from ¥675.8B to ¥3,952.0B, boosting financial income, while insurance finance income/expenses deteriorated from +¥375.7B to △¥2,290.8B; however, the growth in investment income more than absorbed this impact.
Factors Driving Earnings Changes
【Revenue】Insurance revenue increased 14.1% YoY to ¥16,861.9B. By segment, the International Business recorded the largest increase at ¥6,791.4B (40.3% of the total, +32.3% YoY), driving overall growth. Mitsui Sumitomo Insurance, the core domestic non-life insurance business, remained solid at ¥4,851.3B (+4.4%), while Aioi Nissay Dowa Insurance recorded ¥3,500.1B (+3.9%).
【Profit and Loss】Insurance service profit improved 28.0% YoY to ¥2,092.2B, confirming a strengthening of underwriting profitability. In addition, the sharp increase in other investment gains (+¥3,275.7B) boosted profit before tax, which rose to ¥4,409.3B (+33.4%). The effective tax rate was 25.2%, broadly unchanged from 25.0% in the previous year. By segment, Mitsui Sumitomo Insurance posted ¥1,875.4B in profit (+62.8%), Aioi Nissay Dowa Insurance posted ¥877.1B (+67.9%), and the International Business posted ¥964.9B (+111.7%), all representing substantial increases. Meanwhile, MS Primary Life Insurance fell sharply to ¥16.9B from ¥616.8B in the previous year, indicating normalization from the high level driven by market conditions in the previous year. Overall, revenue and earnings increased, with both improved underwriting profit and expanded investment income contributing to the results.
Segment Analysis
Domestic non-life insurance businesses continued to serve as the core source of profit. Mitsui Sumitomo Insurance posted segment profit of ¥1,875.4B (+62.8% YoY), while Aioi Nissay Dowa Insurance posted ¥877.1B (+67.9%), both representing substantial increases. The International Business strengthened its presence as a growth driver, with revenue of ¥6,791.4B (40.3% of the total, +32.3%) and profit of ¥964.9B (+111.7%). Results in the life insurance businesses diverged: MSA Life Insurance improved substantially to ¥143.4B (+401.3%), while MS Primary Life Insurance declined sharply to ¥16.9B from ¥616.8B in the previous year, confirming the normalization of profits from market-linked products. The profit structure across segments is clearly characterized by domestic non-life insurance and international businesses leading growth, while life insurance remains highly volatile.
Key Financial Indicators
【Profitability】The net profit margin was approximately 19.5% (current-period net income of ¥3,297.8B ÷ insurance revenue of ¥16,861.9B), improving from 16.8% in the previous year (¥2,479.8B ÷ ¥14,783.4B). ROE was 4.9%, while the equity ratio was 22.1%, broadly unchanged from 22.1% in the previous year. 【Cash Flow Quality】The sharp increase in other investment gains boosted profit, resulting in a revenue composition highly dependent on market conditions. 【Investment Efficiency】Investments in equity-method affiliates increased 28.8% from the end of the previous fiscal year to ¥11,820.5B, while equity-method investment gains also expanded to ¥148.5B from ¥63.9B in the previous year. 【Financial Soundness】Total assets were ¥301,248.1B and net assets were ¥67,304.9B. The equity ratio was 22.1%, maintaining a level broadly in line with that at the end of the previous fiscal year.
Cash Flow Analysis
Cash and cash equivalents were ¥21,360.4B, down ¥3,777.3B from ¥25,137.7B at the end of the previous fiscal year. Investment securities increased from ¥201,328.3B to ¥204,471.6B, while equity-method investments also increased by ¥2,645.8B, indicating that cash on hand was allocated to expanding securities investments and equity-method investments. Treasury stock increased from ¥1,506.2B to ¥1,928.6B, suggesting that part of the capital allocation was directed toward share repurchases. Collateralized borrowings, including repo transactions, increased from ¥4,816.2B to ¥6,527.2B, indicating flexible use of short-term market funding for liquidity management.
Quality of Earnings
Insurance service profit improved by 28.0% YoY, indicating a strengthening of recurring underwriting profitability. Meanwhile, other investment gains surged from ¥675.8B to ¥3,952.0B, accounting for a significant share of the increase in net income. These investment gains are highly susceptible to market conditions in equities, credit, and other areas, and differ in nature from recurring earnings; this distinction warrants attention. Insurance finance income/expenses shifted from +¥375.7B to △¥2,290.8B. This reflects accounting volatility associated with changes in discount rates and other factors and is effectively the counterpart to the increase in investment gains. The adjustment from profit before tax to net income was largely attributable to the effective tax rate of 25.2% (25.0% in the previous year), with limited divergence attributable to extraordinary gains and losses.
Earnings Forecast and Guidance
The full-year forecast for net income attributable to owners of the parent is ¥4,250.0B, and the Q1 result of ¥3,286.2B represents a high progress rate of approximately 77.3%. This is substantially above the simple time-apportionment benchmark of 25%, reflecting the earlier-than-expected contributions from the sharp increase in other investment gains and profit growth in the International Business and domestic non-life insurance businesses. Full-year forecast EPS is ¥295.75, and progress is also ahead when compared with Q1 EPS of ¥226.84. On a YoY basis, full-year forecast net income is expected to decline 16.8%, suggesting that the forecast incorporates an assumption that the temporary boost from investment gains and other factors will diminish from the second half onward.
Shareholder Returns
The dividend forecast for the fiscal year ending March 2027 is ¥170 annually (¥85 at the end of Q2 [ordinary ¥70 + special ¥15], and ¥85 at year-end [ordinary ¥70 + special ¥15]). The payout ratio based on forecast EPS of ¥295.75 is approximately 57.5%. The annual dividend for the previous fiscal year was ¥160 (ordinary dividend of ¥125 + special dividend equivalent of ¥35), indicating an upward trend in the ordinary dividend. Treasury stock increased from ¥1,506.2B at the end of the previous fiscal year to ¥1,928.6B, suggesting that total shareholder returns, including share repurchases in addition to dividends, are above the payout ratio level.
Risk Factors
-
Market-Dependence Risk of Investment Gains: Other investment gains surged from ¥675.8B to ¥3,952.0B, boosting net income, but a reversal may occur depending on equity and credit market conditions.
-
Volatility Risk of Insurance Finance Income/Expenses: Insurance finance income/expenses shifted from +¥375.7B in the previous year to △¥2,290.8B in the current period, and accounting volatility associated with changes in discount rates and other factors may continue to cause fluctuations in earnings.
-
Normalization Risk in the Life Insurance Segment: Profit at MS Primary Life Insurance fell sharply from ¥616.8B to ¥16.9B, with profit volatility from market-linked products representing a source of volatility in consolidated earnings.
Industry Benchmark (Reference; Compiled by the Company)
Industry Benchmark (insurance)
Profitability and Return
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Net Profit Margin | 19.6% | 3.4% (-1.2%–24.6%) | +16.2pt |
The net profit margin is substantially above the industry median and ranks at a high level within the industry.
Growth and Capital Efficiency
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Revenue Growth Rate (YoY) | 14.1% | 9.3% (2.0%–17.3%) | +4.8pt |
The revenue growth rate also exceeds the industry median, indicating a relatively favorable position in terms of growth.
Source: Compiled by the Company
Key Points from the Earnings Results
-
Although the full-year progress rate is high at approximately 77%, the substantial contribution from the market-dependent factor of sharply increased investment gains should be noted when assessing earnings sustainability.
-
Segment profit at the domestic non-life insurers (Mitsui Sumitomo Insurance and Aioi Nissay Dowa Insurance) and the International Business each increased substantially, confirming improved underwriting profitability. Meanwhile, the sharp decline in profit at MS Primary Life Insurance indicates variation in revenue sources within the Group.
-
The payout ratio is approximately 57.5%, and treasury stock has also increased, indicating an active approach to shareholder returns through both dividends and share repurchases.
This report is an earnings analysis document automatically generated by AI based on XBRL earnings release data. It does not constitute a recommendation to invest in any specific security. The industry benchmarks are reference information compiled by the Company based on publicly available earnings data. Investment decisions should be made at your own discretion and responsibility, after consulting with a professional adviser as necessary.
---End of Report---
AI Financial Analysis
Executive Summary
MS&AD delivered a strong FY2027 Q1 result, with attributable profit materially ahead of the run-rate implied by its unchanged full-year forecast. Insurance revenue rose 14.1% YoY to ¥1,686.2bn. Net income rose 33.4% YoY to ¥328.6bn, while profit before tax increased 33.4% to ¥440.9bn. Basic EPS increased to ¥226.84 from ¥162.99. The net profit margin expanded by 283bp to 19.5% from 16.7% in the prior-year quarter. Insurance service profit increased 28.0% to ¥209.2bn. Insurance service profit as a proportion of insurance revenue improved by approximately 135bp to 12.4%, indicating improved underlying insurance profitability. Financial profit also increased, with net financial profit rising to ¥245.7bn from ¥175.2bn. The main driver was a sharp increase in other investment gains to ¥395.2bn from ¥67.6bn. This investment gain more than offset the adverse swing in insurance finance results, which moved to a ¥229.1bn loss from a ¥37.6bn gain. Equity-method investment income more than doubled to ¥14.9bn, adding to pre-tax earnings growth. Comprehensive income increased 17.1% to ¥413.8bn, supported by ¥84.0bn of other comprehensive income. The annualized DuPont ROE was 19.5%, an excellent level, but the quarter's investment-result contribution means the earnings mix should be assessed cautiously. Q1 attributable profit represents 77.3% of the ¥425.0bn full-year forecast, versus a standard first-quarter progress rate of 25%, a positive deviation of 52.3 percentage points. The unchanged forecast despite this substantial Q1 progress suggests management is retaining caution for catastrophe losses, reserve developments, market movements and seasonal earnings volatility. The FY2027 full-year dividend forecast of ¥170 per share is unchanged and implies a forecast payout ratio of 57.5%, consistent with a meaningful but not excessive shareholder-return commitment.
Profitability Analysis
Annualized DuPont ROE is 19.5%, comprising a 19.5% net profit margin, 0.224x annualized asset turnover and 4.48x financial leverage. The elevated ROE is led principally by the strong net margin and the balance-sheet leverage inherent in insurance operations, rather than by high asset turnover. Net margin improved by 283bp YoY, reflecting net income growth of 33.4% exceeding insurance revenue growth of 14.1%. The largest earnings swing came from investment performance: other investment gains increased by ¥327.6bn YoY to ¥395.2bn. This was partly offset by insurance finance results, which deteriorated by ¥266.6bn YoY to a ¥229.1bn loss, illustrating the sensitivity of IFRS insurance earnings to financial-market and discount-rate movements. Underlying insurance service profit nonetheless rose ¥45.8bn YoY to ¥209.2bn, faster than insurance revenue, supporting the improvement in insurance service profitability. The effective tax rate was 25.2%, and the tax burden ratio of 74.5% is within a normal range. The core business by segment profit contribution was Mitsui Sumitomo Insurance within domestic P&C, generating ¥187.5bn of segment profit, up 62.8% YoY, on external revenue growth of 4.4% to ¥485.1bn. Aioi Nissay Dowa Insurance generated ¥87.7bn of profit, up 68.0%, on revenue growth of 3.9% to ¥350.0bn. Overseas operations generated ¥96.5bn of profit, up 111.6%, while external revenue increased 32.3% to ¥679.1bn; overseas business was the largest segment by external revenue. Domestic life insurance showed divergent performance: Mitsui Sumitomo Aioi Life profit rose to ¥14.3bn from ¥2.9bn, whereas Mitsui Sumitomo Primary Life profit declined sharply to ¥1.7bn from ¥61.7bn despite revenue growth of 32.3%. Consolidation and head-office adjustments widened to a negative ¥67.1bn from negative ¥35.0bn, reducing the conversion of aggregate segment profit into attributable profit.
Growth Assessment
Revenue growth was broad-based, with consolidated insurance revenue increasing ¥207.8bn YoY. Overseas revenue growth of ¥165.9bn accounted for approximately 80% of the consolidated revenue increase, underscoring its importance to current growth. Domestic P&C revenue expanded at a more moderate pace, with Mitsui Sumitomo Insurance and Aioi Nissay Dowa Insurance together adding ¥33.3bn of external revenue. Overseas profit growth exceeded revenue growth, indicating strong operating and investment contribution in the quarter, although this growth profile can be more variable than domestic underwriting income. Domestic life growth was led by Primary Life revenue, but its profit contraction highlights that premium or revenue growth does not necessarily translate directly into quarterly profit expansion under IFRS. Equity-method income rose by ¥8.5bn YoY to ¥14.9bn, providing an additional source of earnings diversification. The reported multi-period margin trend is stable, although the growth consistency score of 2/10 indicates a historically uneven growth pattern. The ¥425.0bn full-year attributable-profit forecast implies a 16.8% YoY decline, despite exceptionally strong first-quarter results. This conservative full-year outlook indicates that quarterly investment gains should not be extrapolated mechanically. The key forward issue is whether improved insurance service profitability can sustain earnings if investment gains normalize.
Financial Health
Total assets increased by ¥532.7bn from FY2026 year-end to ¥30,124.8bn at June 2026. Total equity increased by ¥249.3bn to ¥6,730.5bn, and the equity ratio improved to 22.1% from 21.7%. Retained earnings increased by ¥261.8bn to ¥5,190.1bn, reflecting profitable operations during the quarter. Investments accounted for a substantial share of assets, including ¥20,447.2bn of investment securities and ¥1,182.1bn of equity-method investments, which is consistent with the asset-intensive nature of a large insurer. The reported D/E ratio of 3.48x exceeds the 2.0x high-leverage warning threshold and should be treated as a formal solvency-risk alert. Its root cause is that total liabilities include ¥18,859.4bn of insurance contract liabilities, which are operating policyholder obligations rather than conventional financial borrowings. Consequently, the reported D/E ratio overstates the economic significance of debt financing relative to a non-financial company. Nevertheless, the balance sheet contains ¥1,044.3bn of bonds and borrowings and ¥652.7bn of repo and similar secured borrowings, so funding-market conditions and collateral management remain important. Repo and similar secured borrowings increased ¥171.1bn from year-end, while cash and cash equivalents declined ¥377.7bn to ¥2,136.0bn. This combination warrants monitoring for liquidity and maturity-management discipline, although substantial investment securities provide an important liquidity reservoir. Treasury stock increased by ¥42.2bn, or 28.0%, to negative ¥192.9bn, which reduces reported equity but may enhance per-share metrics. Intangible assets were only 1.1% of total assets, limiting balance-sheet concentration in acquired intangible value.
Notable B/S Changes
Cash and cash equivalents: -¥377.7bn (-15.0% from FY2026 year-end) to ¥2,136.0bn - monitor alongside higher secured funding and investment deployment. Investment securities: +¥314.3bn (+1.6%) to ¥20,447.2bn - reinforces the importance of market valuation, interest-rate exposure and portfolio liquidity. Investments accounted for using the equity method: +¥264.6bn (+28.8%) to ¥1,182.1bn - increased exposure to affiliate earnings and valuation performance. Repo transactions and other similar collateralized borrowings: +¥171.1bn (+35.5%) to ¥652.7bn - raises the importance of collateral and short-term funding management. Insurance contract liabilities: +¥254.6bn (+1.4%) to ¥18,859.4bn - reflects the core policyholder-liability base and reinforces asset-liability matching requirements. Treasury stock: -¥42.2bn (-28.0%) to -¥192.9bn - reduced equity and increased the significance of capital-allocation discipline.
Cash Flow Quality
Cash and cash equivalents declined by ¥377.7bn from FY2026 year-end to ¥2,136.0bn at June 2026. The quarter also saw investment securities increase by ¥314.3bn and equity-method investments increase by ¥264.6bn, consistent with active deployment or valuation changes within the investment portfolio. For an insurer, cash-balance movements must be considered alongside investment-portfolio liquidity, policyholder liabilities and collateralized funding rather than in isolation. The strong ¥328.6bn net income result was supported materially by investment gains, particularly the ¥395.2bn of other investment gains. Accordingly, the durability of earnings depends partly on the recurrence of investment-market conditions, not solely on insurance service income. The increase in insurance service profit to ¥209.2bn provides a more recurring earnings foundation than market-sensitive investment gains. Insurance contract liabilities rose ¥254.6bn during the quarter, broadly consistent with the scale of the insurance franchise and requiring continued asset-liability matching discipline.
Dividend Sustainability
The FY2027 forecast dividend is ¥170 per share, comprising expected interim and year-end payments of ¥85 each. Based on forecast EPS of ¥295.75, the forecast dividend payout ratio is 57.5%. This is below the 60% sustainability benchmark and leaves a moderate earnings retention buffer. Q1 basic EPS of ¥226.84 already exceeds the ¥170 full-year dividend per share, although quarterly EPS should not be extrapolated because the quarter benefited from strong investment gains. Retained earnings increased to ¥5,190.1bn, providing a substantial accumulated capital base. The unchanged dividend forecast alongside unchanged earnings guidance indicates that management has not yet treated the strong first-quarter result as a basis for increasing shareholder distributions. The 28.0% increase in treasury stock indicates additional capital allocation activity affecting per-share value, but dividend payout should remain assessed separately from share repurchases. The principal determinant of dividend resilience is the ability to maintain underlying insurance-service profitability through market volatility and catastrophe-loss cycles.
Risk Assessment
Business risks include Catastrophe and large-loss risk is inherent in domestic P&C operations; adverse natural-disaster experience could quickly reduce insurance service profit., Overseas operations generated ¥679.1bn of revenue and ¥96.5bn of profit, making foreign underwriting conditions, local regulation, foreign exchange and regional catastrophe exposure increasingly material., Primary Life profit fell 97.3% YoY to ¥1.7bn despite revenue growth, demonstrating sensitivity of life-insurance profitability to product mix, financial markets and IFRS measurement effects., Investment earnings were a major driver of the quarter, with other investment gains rising ¥327.6bn YoY; normalization or reversal of market gains would pressure earnings growth..
Financial risks include The reported D/E ratio of 3.48x is above the 2.0x warning level. While insurance liabilities are a major component of this measure, the balance sheet still contains meaningful repo funding and bonds and borrowings., Repo and similar secured borrowings increased to ¥652.7bn, creating sensitivity to collateral values, market liquidity and short-term funding conditions., Debt-investment OCI was negative ¥57.1bn, indicating interest-rate and bond-valuation sensitivity within the investment portfolio., Deferred tax liabilities increased to ¥916.3bn, reflecting the significance of unrealized gains and valuation-related balance-sheet exposures..
Key concerns include The largest near-term issue is earnings-mix durability: Q1 attributable profit reached 77.3% of the full-year forecast because investment-related gains were exceptionally strong., The forecast implies a 16.8% full-year profit decline despite Q1 strength, emphasizing management's expectation of substantial volatility or normalization later in the year., Insurance finance results swung to a ¥229.1bn loss, partly offsetting investment gains and highlighting sensitivity to discount-rate movements., The ¥42.2bn increase in treasury stock reduces equity and should be weighed against capital needs associated with underwriting, market risk and overseas expansion..
Investment Implications
Key takeaways include Q1 earnings were strong: attributable profit rose 33.4% YoY to ¥328.6bn and the net margin expanded to 19.5%., Underlying insurance service profit rose 28.0% to ¥209.2bn, supporting the quality of the operating result., Investment gains were the largest incremental earnings driver and introduce greater uncertainty around repeatability., The annualized 19.5% ROE is excellent, but it is supported by both high financial leverage and a strong quarterly investment result., The unchanged ¥425.0bn full-year profit forecast remains highly conservative relative to Q1 progress..
Metrics to watch include Insurance service profit and its margin relative to insurance revenue, Other investment gains and insurance finance gains or losses, Overseas segment profit and foreign-exchange translation effects, Primary Life segment profitability, Repo and similar secured borrowings relative to cash and liquid investment securities, Equity ratio, treasury-stock movements and the reported D/E ratio, Progress toward the ¥425.0bn FY2027 attributable-profit forecast.
Regarding relative positioning, MS&AD combines a large domestic P&C earnings base with a rapidly expanding overseas revenue contribution and a substantial investment portfolio. Its Q1 annualized ROE of 19.5% and forecast dividend payout ratio of 57.5% indicate strong earnings capacity and shareholder-return capacity, while the scale of insurance liabilities, market-sensitive investment gains and secured funding requires an insurer-specific rather than conventional industrial-company leverage assessment.